Who owns BioXcel Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BTAI from SEC Form 13F filings across 47 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 47 institutions disclosed 6.2M shares of BioXcel Therapeutics, Inc. worth $8.7M — about 20.4% of shares outstanding; the largest disclosed holder is MILLENNIUM MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
47
13F holders
$8.7M
value, 2026 filers
20.4%
of shares outstanding (6.2M sh)
11
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BTAI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 2.1M | $3.0M | 0.0% | 7% | +9.2% |
| 2 | OAKTREE CAPITAL MANAGEMENT LP | 1.4M | $1.9M | 0.0% | 4.6% | +472.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 919,545 | $1.3M | 0.0% | 3% | +343.5% |
| 4 | Oaktree Fund Advisors, LLC | 245,585 | $346,274 | 0.6% | 0.8% | +472.3% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 242,251 | $341,911 | 0.0% | 0.8% | +5.2% |
| 6 | BlackRock, Inc. | 179,433 | $253,001 | 0.0% | 0.6% | +112.9% |
| 7 | UBS Group AG | 158,065 | $222,871 | 0.0% | 0.5% | +199.4% |
| 8 | CITADEL ADVISORS LLCNEW | 149,220 | $210,400 | 0.0% | 0.5% | new |
| 9 | VANGUARD FIDUCIARY TRUST CO | 136,937 | $193,081 | 0.0% | 0.5% | +61.3% |
| 10 | STATE STREET CORP | 92,118 | $129,886 | 0.0% | 0.3% | 0.0% |
| 11 | FMR LLC | 90,300 | $127,323 | 0.0% | 0.3% | 0.0% |
| 12 | &PARTNERS | 83,588 | $117,859 | 0.0% | 0.3% | +3.4% |
| 13 | JONES FINANCIAL COMPANIES LLLP | 63,139 | $82,712 | 0.0% | 0.2% | -52.1% |
| 14 | NORTHERN TRUST CORP | 56,318 | $79,408 | 0.0% | 0.2% | +55.1% |
| 15 | HighTower Advisors, LLC | 41,000 | $57,810 | 0.0% | 0.1% | 0.0% |
| 16 | Quadrature Capital LtdNEW | 38,038 | $53,634 | 0.0% | 0.1% | new |
| 17 | Headlands Technologies LLCNEW | 25,556 | $36,034 | 0.0% | 0.1% | new |
| 18 | StoneX Group Inc.NEW | 20,684 | $29,164 | 0.0% | 0.1% | new |
| 19 | Beacon Pointe Advisors, LLC | 18,837 | $26,561 | 0.0% | 0.1% | -0.2% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 17,200 | $24,252 | 0.0% | 0.1% | new |
| 21 | Portfolio Strategies, Inc. | 16,831 | $23,732 | 0.0% | 0.1% | +38.2% |
| 22 | OSAIC HOLDINGS, INC. | 16,214 | $22,860 | 0.0% | 0.1% | 0.0% |
| 23 | Virtu Financial LLCNEW | 15,967 | $23,000 | 0.0% | 0.1% | new |
| 24 | Diversify Advisory Services, LLCNEW | 15,000 | $13,005 | 0.0% | 0% | new |
| 25 | DIVERSIFY WEALTH MANAGEMENT, LLC | 15,000 | $13,005 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.